Our main hypothesis was that HR expression has a prognostic role in HR+/HER2– IBC and that HR+/HER2– IBC has specific GE in the ER signaling pathway that characterizes aggressive biological behavior. Here, ESR1 is linked to inflammatory breast carcinoma.